Defense Health Program Department of Defense Lung Cancer Research Program Funding Opportunities for Fiscal Year 2021 (FY21)

How to Apply: 

As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).

 

Subject to the FY21 Congressional appropriation for LCRP funding, FY21 LCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.    

 

Applications submitted to the FY21 LCRP must address one or more of the following Areas of Emphasis:

 

  • Identify innovative strategies for prevention of the occurrence of lung cancer.
  • Identify innovative strategies for the screening and early detection of lung cancer.
  • Understand the molecular mechanisms of initiation and progression to lung cancer.
  • Understand contributors to lung cancer development other than tobacco.
  • Identify innovative strategies for the treatment of lung cancer.
  • Identify innovative strategies for the prevention of recurrence of or metastases from lung cancer.
  • Develop or optimize prognostic or predictive markers to assist with therapeutic decision-making.
  • Understand mechanisms of resistance to treatment (primary and secondary).
  • Identify innovative strategies for lung cancer care delivery (clinical management/surveillance/symptom management).
  • Understand factors that contribute to the health disparities in lung cancer, such as biological contributors; environmental, social, and cultural factors; and access to health care.

https://cdmrp.army.mil/funding/lcrp

 

Concept Award – Letter of Intent Due April 6, 2021

All investigators at or above the level of postdoctoral fellow (or equivalent)

  • Supports highly innovative, untested, potentially groundbreaking concepts in lung cancer.
  • Emphasis on innovative concept or untested theory.
  • Research involving human subjects or specimens must be either exempt under Title 32, Code of Federal Regulations (CFR), Part 219, Section 104(d)(32 CFR 219.104[d]) or eligible for expedited review (21 CFR 56.110).
  • Clinical trials not allowed.
  • Preliminary data discouraged (not consistent with intent of award mechanism).
  • Military relevance strongly encouraged.
  • Maximum funding of $100,000 in direct costs (plus indirect costs).
  • Period of performance should not exceed 1 year.

 

Career Development Award – Letter of Intent Due April 6, 2021

  • Principal Investigator:  Independent investigators at the level of Assistant Professor, Instructor, or equivalent; must be within 5 years of first faculty appointment (or equivalent)
  • Most not have received a Career Development Award previously from any program within the Congressionally Directed Medical Research Programs.
  • Must not have received more than $300,000 in total direct costs for previous or concurrent lung cancer research as a PI of one or more federally or privately funded, non-mentored, peer-reviewed grants.

Mentor:  At or above the level of Associate Professor (or equivalent),

Must have a strong publication and funding record in lung cancer research

  • Supports early-career, independent researchers to conduct research under mentorship of an experienced lung cancer researcher.
  • Emphasis on research with high potential impact.
  • Clinical trials not allowed.
  • Career development plan is required with appropriate mentor guidance.
  • Preliminary data not required.
  • Military relevance strongly encouraged.
  • Maximum funding of $250,000 in direct costs (plus indirect costs).
  • Period of performance should not exceed 2 years.

 

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

 

For more information about the LCRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

 

Point of Contact:

CDMRP Help Desk

301-682-5507 
help@eBrap.org

External Deadline: 
Tuesday, April 6, 2021
URL: 

https://cdmrp.army.mil/funding/lcrp

Agency: 
Department of Defense
Funding Source: 
External
Funding Level: 
Research